Research on Security Enhancement Methods for Adversarial Robust Large Language Model Intelligent Agents for Medical Decision-Making Tasks

Researchers developed ARSM-Agent, a security-enhanced framework for medical decision-making AI systems that defends against adversarial attacks through multi-module validation. The system reduces attack success rates to 8.7% while maintaining 91% knowledge consistency, demonstrating significant improvements over existing baseline approaches.

This research addresses a critical vulnerability in deploying large language models for high-stakes medical applications. Medical AI systems face unique security challenges because adversarial attacks—ranging from prompt injection to drug-name confusion—can directly compromise patient safety. The ARSM-Agent framework implements a comprehensive defense strategy spanning input validation, evidence verification, and confidence scoring, treating security as an integrated component rather than an afterthought.

The work builds on growing recognition that LLMs require adversarial robustness for clinical deployment. Prior approaches either ignored security concerns or applied generic adversarial training, missing medical-specific attack vectors. This study's weighted multi-objective approach (balancing accuracy, robustness, safety refusal, and knowledge consistency) reflects the complex tradeoffs inherent in medical AI.

The ablation studies reveal meaningful contributions from each defense layer, with evidence retrieval and risk perception providing the largest security gains (11.1% and 13.8% attack success rate increases when removed). The 8.7% residual attack success rate suggests practical deployment viability, though not absolute impermeability. For healthcare organizations evaluating LLM integration, this framework provides a template for security assessment and module prioritization based on resource constraints.

Looking forward, the field must address whether these defenses scale to larger models and broader medical domains. Regulatory bodies considering AI approval standards should evaluate whether 8.7% residual attack success meets clinical risk tolerances. The research signals that secure medical AI requires domain-aware security architecture rather than generic robustness techniques—a principle applicable beyond healthcare.

• →ARSM-Agent reduces adversarial attack success rates to 8.7% through multi-module security architecture specifically designed for medical decision-making
• →Evidence retrieval and input risk perception modules contribute the largest security gains, improving attack resistance by 11.1% and 13.8% respectively
• →The framework achieves 0.91 knowledge consistency score while maintaining competitive decision accuracy, addressing the security-performance tradeoff
• →Ablation analysis demonstrates that integrated defense layers outperform single-technique baselines across four attack types including prompt injection and drug-name confusion
• →Healthcare organizations deploying LLM-based decision support systems gain a validated framework for adversarial robustness assessment and implementation